Literature DB >> 31994195

Learning curve for sentinel lymph node mapping in gynecologic malignancies.

Seongmin Kim1,2, Ki Jin Ryu2, Kyung Jin Min2, Sanghoon Lee2, Un Suk Jung3, Jin Hwa Hong2, Jae Yun Song2, Jae Kwan Lee2, Nak Woo Lee2.   

Abstract

BACKGROUND AND OBJECTIVES: Only a few studies have reported the learning curve for sentinel lymph node (SLN) detection in gynecologic malignancies. We investigated the learning curve for SLN detection during robot-assisted laparoscopic surgery for endometrial and cervical carcinomas.
METHODS: This retrospective analysis included patients with stage IA to IIA1 cervical cancer or stage I to III endometrial cancer who underwent SLN mapping using indocyanine green during robot-assisted laparoscopic surgery performed by a single surgeon. Learning curves were analyzed in consecutive cases using SLN detection rates and the cumulative sum (CUSUM) method.
RESULTS: SLN mapping was achieved in 81.25% (65/80), 77.50% (62/80), and 66.25% (53/80) of the cases involving the right, left, and simultaneous bilateral pelvic areas, respectively. Learning curve analysis based on the cumulative detection rate showed initial fluctuations followed by stabilization; the time required for proficiency was discordant among the LN regions. However, the CUSUM method showed proficient mapping of the right, left, and bilateral SLNs after 27 to 28 cases.
CONCLUSION: At least 27 cases were required for SLN mapping proficiency in gynecologic cancer; the learning period could influence the surgical quality. Further studies are warranted to confirm the impact of this learning curve on disease outcomes.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  cervical cancer; endometrial cancer; learning curve; sentinel lymph node

Year:  2020        PMID: 31994195     DOI: 10.1002/jso.25853

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  The impact of low-volume metastasis on disease-free survival of women with early-stage cervical cancer.

Authors:  Alessandro Buda; Jvan Casarin; Michael Mueller; Francesco Fanfani; Ignacio Zapardiel; Liliana Mereu; Andrea Puppo; Elena De Ponti; Marco Adorni; Debora Ferrari; Maria Luisa Gasparri; Fabio Ghezzi; Giovanni Scambia; Andrea Papadia
Journal:  J Cancer Res Clin Oncol       Date:  2020-11-01       Impact factor: 4.553

2.  Sentinel Lymph Node Biopsy in Endometrial Cancer: Dual Injection, Dual Tracer-A Multidisciplinary Exhaustive Approach to Nodal Staging.

Authors:  Anna Torrent; Joana Amengual; Catalina Maria Sampol; Mario Ruiz; Jorge Rioja; Gabriel Matheu; Pilar Roca; Octavi Cordoba
Journal:  Cancers (Basel)       Date:  2022-02-13       Impact factor: 6.639

Review 3.  Should Endometrial Cancer Treatment Be Centralized?

Authors:  Vincenzo Dario Mandato; Andrea Palicelli; Federica Torricelli; Valentina Mastrofilippo; Chiara Leone; Vittoria Dicarlo; Alessandro Tafuni; Giacomo Santandrea; Gianluca Annunziata; Matteo Generali; Debora Pirillo; Gino Ciarlini; Lorenzo Aguzzoli
Journal:  Biology (Basel)       Date:  2022-05-18

4.  Surgical Outcomes of Transperitoneal Para-Aortic Lymphadenectomy Compared With Extraperitoneal Approach in Gynecologic Cancers: A Systematic Review and Meta-Analysis.

Authors:  Kun-Peng Li; Xian-Zhong Deng; Tao Wu
Journal:  Front Surg       Date:  2021-12-21

5.  Association Study between the Sentinel Lymph Node Biopsy and the Clinicopathological Features of Patients with Cervical Cancer.

Authors:  Gaoli Niu; Yajuan Ren; Yanhong Zhai
Journal:  Dis Markers       Date:  2022-08-26       Impact factor: 3.464

6.  Indocyanine green versus technetium-99m with blue dye for sentinel lymph node detection in early-stage cervical cancer: A systematic review and meta-analysis.

Authors:  Ilse G T Baeten; Jacob P Hoogendam; Bernadette Jeremiasse; Arthur J A T Braat; Wouter B Veldhuis; Geertruida N Jonges; Ina M Jürgenliemk-Schulz; Carla H van Gils; Ronald P Zweemer; Cornelis G Gerestein
Journal:  Cancer Rep (Hoboken)       Date:  2021-05-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.